Sandoz Hit With Patent Suit Over Bausch's IBS Drug Xifaxan
By Jeannie O'Sullivan ( October 1, 2019, 6:55 PM EDT) -- Bausch Health and its gastrointestinal medicine subsidiary said Tuesday that they sued Novartis unit Sandoz Inc. for allegedly infringing 14 patents for the irritable bowel syndrome drug Xifaxan....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.